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ABSTRACT         ARTICLE INFO______________________________________________________________     ______________________
Purpose: To compare dietary, lifestyle, clinical, anthropometric, genetic and prostatic 
features of Brazilian Indians and non-Indians (Amazon).
Methods: 315 men, 228 Indians and 89 non-Indians, ≥40 years old were submitted to 
digital rectal examination, serum prostate specific antigen (PSA), testosterone, TP53 
and GSTP1 genotyping, anthropometric, lifestyle, dietary, personal and familial medi-
cal history. Prostatic symptoms were evaluated with the International Prostate Symp-
tom Score (IPSS).
Results: Macuxis and Yanomamis represented 43.6% and 14.5% of Indians respectively 
who spontaneously referred no prostate symptoms. Mean IPSS was 7, range 3-19, with 
only 15% of moderate symptoms (score 8-19); Mean age was 54.7 years, waist circu-
mference 86.6 cm, BMI 23.9 kg/m2. Yanomamis presented both lower BMI (21.4 versus 
24.8 and 23.3, p=0,001) and prostate volume than Macuxis and “other ethnic groups” 
(15 versus 20, p=0.001). Testosterone (414 versus 502 and 512, p=0.207) and PSA (0.48 
versus 0.6 and 0.41, p=0.349) were similar with progressive PSA increase with aging. 
Val/Val correlated with lower PSA (p=0.0361).
Indians compared to control population presented: - TP53 super representation of Arg/
Arg haplotype, 74.5% versus 42.5%, p<0.0001. -GSTP1 Ile/Ile 35.3% versus 60.9%; Ile/
Val 45.9% versus 28.7%; Val/Val 18.8% versus 10.3%; p=0.0003.
Conclusions: Observed specific dietary, lifestyle, anthropometric and genetic profile for 
TP53 and GSTP1 may contribute to Brazilian Indian population prostate good health.
Key words:
Prostatic Diseases; Neoplasms; 
Tumor Suppressor Protein 
p53; GSTP1 protein, human 
[Supplementary Concept]; 
Testosterone; Genetic Therapy; 
Polymorphism, Genetic








The Indian populations in Brazil and in 
other countries worldwide are not well studied, 
with rare published reports. The study of culturally 
distinct indigenous populations, as well as their 
contact with and influence of non-indigenous 
groups in relation to their behavior and merging 
of new habits as risk factors for prostate diseases 
is intriguing.
 Many studies have been reporting for 
many years the huge ethnical difference of the 
incidence of prostate diseases, including prostate 
cancer (PCa) as well as the concentration of pros-
tatic specific antigen (PSA) in different popula-
tions around the World (1). It is discussed if these 
differences are derived from biological diversity 
of populations or from environmental factors that 
would modify their hereditary traits, mainly dieta-
ry habits and lifestyle (2).
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Age, black race and familial history of 
cancer are well stablished factors for high risk of 
prostate cancer (1). Most studies suggest that the 
ingestion of fatty food, cooked food, selenium, ex-
posure to pesticides and fertilizers, physical activity 
and socio-economic status are factors that can con-
tribute to observed differences in many countries, 
regions or eventually races (3).
Variations of frequency of PCa among Cau-
casians, native Alaskans and Indians are well do-
cumented in the USA (4, 5). However, in the indige-
nous population of Brazil, data regarding incidence, 
prevalence and risk factors for prostate disease are 
rare and only a few studies addressed clinical and 
anthropometric data in that population (6-8).
In view of scarce information about the 
profile of male health of indigenous populations 
of extreme North of Brazil, we decided to analyze 
GSTP1 and TP53 polymorphisms, PSA and tes-
tosterone serum values and digital rectal exam, 
correlating the results with anthropometric cha-
racteristics, lifestyle, and especially dietary habits 
in order to elucidate the interaction of genetic ba-
ckground and environmental exposure in relation 
to prostatic diseases.
MATERIALS AND METHODS
From March, 2010, to March, 2011, a to-
tal of 315 healthy men with 40 or more years old 
were prospectively evaluated by the same exa-
miner, after signing a written consent form. 228 
Indians were admitted to Indian House of Health 
in Boa Vista, Roraima, Brazil (CASAI/RR), through 
a campaign, and 87 non-indigenous healthy men 
that donated blood were included in the control 
group. They resided in the Boa Vista Region, Bra-
zil. Those who presented a personal or family his-
tory of prostate cancer were excluded.
Polymorphisms of codon 72 of TP53 and 
GSTP1 were analyzed; they are involved in the 
detoxification and repair of DNA (9) (Figure-1). 
The data were correlated to anthropometric va-
lues, lifestyle habits, serum PSA and testosterone 
and digital rectal exam (DR) of the indigenous po-
pulations of northern Brazil. Prostatic symptoms 
were evaluated with the IPSS (International Pros-
tate Symptom Score) questionnaire validated to 
Portuguese (10).
Genomic DNA was extracted using the 
standard protocol of phenol-chlorophorm, adap-
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Figure 1 - Mechanism of detoxification and repair of DNA related to TP53 and GSTP1.
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ted from the Cancer Genetic Molecular Laboratory 
of the University of Campinas-Unicamp, Brazil. In 
order to verity the DNA purity and quality of the 
extract, the samples were quantified using the UV-
-spectrophotometer Picodrop Limited (Cambrid-
geshire, UK).
Genotyping of the two proposed poly-
morphisms GSTP1 codon 105 (rs1695) and TP53 
codon 72 (rs1042522) was conducted using Ta-
qMan® SNP Genotyping (7500 Real Time PCR 
Systems) essay.
In order to understand the impact of the 
introduction of new dietary habits, lifestyle and 
behaviors from the non-indigenous population, 
we identified and compared two different ethnic 
groups, with bigger and smaller distance from the 
urban centers, with consequent greater of smaller 
contact and merging of habits of non-indigenous 
people: respectively, Macuxis and Yanomamis.
All local authorities were officially notified 
(FUNASA and CASAI), and agreed with this research.
Statistical analysis
Categorical variables were compared using 
the exact Fisher test of Chi-square test, as appropria-
ted. Non-normally distributed numerical variables 
were compared using the Mann-Whitney test (two 
groups) or Kruskal-Wallis (three of more groups).
The analysis of allelic and genotypic fre-
quencies was made using the laws of equilibrium 
of Hardy-Weinberb. Values with P<0.05 were con-
sidered statistically significant.
RESULTS
No Indian reported prostatic symptoms; 
median age was 54.7 years, abdominal circu-
mference was 86.6 cm and BMI was 23.9 kg/
m2; 64.8% had normal BMI (18.5 to 25,0 kg/m2), 
29.5% overweight (25,0 to 30 kg/m2), 3.5% obesi-
ty (≥30.0 kg/m2) and 2.2% low weight (<18.5 kg/
m2). Median PSA was 0.52 with values ≤2.5 ng/
mL in 91.3%, >2.5 ng/mL in 9 cases (8.7%), and 
5.8% with PSA ≥4 ng/mL (Table-1). Control group 
is described at Table-2.
83 Indians completed the question form; 
mean age was 53 years. Most informed absence of 
Table 1 - Clinical and laboratory characteristics of Indians 
(n=228).
Characteristic Value or n
Age, years




Interval 17.3 to 33.8
Mean±SD 23.94±3.11
Meann 23.9
Abdominal circumference, cm 










Interval 14 to 889
Mean±SD 495±1.78
Median 472
Digital rectal exam, grams (n=224)




Interval 0.02 to 13.95
Mean±SD 1.10±1.89
Median 0.52
symptoms or light symptoms (score ≤7) and only 
15% moderate symptoms (score 8-19); IPSS varied 
from 3 to 19, median 7.
Cassava (manioc) (98.7%), fish (25.2%) and 
animal hunt meat (86.4%) were the most frequent 
food ingested during basic Indian meals, followed 
by flour (41.7%), fruits (28.9%) and vegetables 
(27.2%). Meat, chicken and pork were referred 
only by 17.1%, 16.7% and 5.7% respectively.
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When the ethnic groups were compared, 
the Yanomamis were younger with lower values 
of BMI and lower prostate volume at DR. There 
were no differences between testosterone and PSA 
levels, and PSA increased with age (Table-3).
Indian and non-indigenous showed super-
-representation of haplotype Arg/Arg, 74.5% ver-
sus 42.5%, p<0.0001, polymorphism TP53 and 
Ile/Ile 35.3% versus 60.9%; Ile/Val 45.9% ver-
sus 28.7% and Val/Val 18.8% versus 10.3%, for 
GSTP1, p=0.0003, respectively (Table-4).
We observed an association of GSTP1 ge-
notype and serum PSA, with predominance of 
polymorphic homozygous genotype Val/Val in in-
dividuals with lower PSA levels (p=0.0361).
Tables 5 and 6 show demographic and cli-
nical characteristics, according to variants of TP53 
and GSTP1, respectively.
DISCUSSION
Our data show that the indigenous popu-
lation presents low prostate volume, BMI close 
to normality and healthy dietary habits, different 
from the Brazilian population. Also, Indians pre-
sent lower incidence of prostatic symptoms (ac-
cording to IPSS, only 15% moderate) in relation 
to non-indigenous Brazilians with same age eva-
luated in a screening program of prostate cancer 
(29%, with 24% of moderate symptoms and 5% 
with severe symptoms (11).
Among the ethnic groups, the Yanomamis 
were younger, with lower values of BMI and pros-
tatic volume, although with similar serum values 
of PSA and testosterone.
The analysis of polymorphism of TP53 co-
don 72 and GSTP1 demonstrated significant diffe-
rences between Indians and non-indigenous and 
the homozigous polymorphic genotype Val/Val 
was related to significant lowers levels of serum 
PSA.
These differences may be related to age di-
fferences, but also due to behavior and dietary ha-
bits between the ethnic groups, although without 
clinical significant difference of age in regard to 
prostatic evaluation. The greater contact of the 
Macuxi population with non-indigenous popula-
tions may have merged new behavior and dietary 
habits similar to non-Indians.
In contrast, the greater geographic dis-
tance from urban centers may have contributed 
to preservation of dietary habits and lifestyle of 
the Yanomamis. In this group, all participants 
ate animal hunt meat and fish, none reported 
ingestion of bovine meat and only two reported 
chicken ingestion.
Also, genetic differences associated to ra-
cial and ethnical factors have influence on the 
predisposition to prostatic diseases. Recently our 
group identified genetic polymorphisms related 
to the metabolism of carcinogens that can distin-
guish patients with high or low risk of PCa or be-
nign prostatic hyperplasia (12).
The incidence of prostate cancer in the 
Brazilian Indian population is unknown. At “Hos-
pital Geral de Roraima (Saúde Indígena Hospita-
lar)”, reference to this ethnical group, there were 
10 cases per year (median) in the last 5 years.
Several studies have demonstrated that 
American Indians present low risk for PCa (13-
15). In one of the first studies that described the 
epidemiological profile of Indians compared to 
white Americans, Dunham et al. (1973) identified 
similar prevalence of PCa among groups (5). On 
the contrary, Gilland et al. (1998) found different 
patterns of incidence and mortality of PCa among 
American Indians, blacks, Hispanics from New 




Interval 18 to 86
Mean±SD 41.1±15.3







IQR= interval interquartis; SD= standard deviation
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P (Macuxi x 
Yanomami)
P (Macuxi x Yanomami x 
Other ethnical groups)
Age, years n=99 n=33 n=95
Interval 40 to 91 40 to 73 40 to 81
0.002 0.0034Mean±SD 57.7±13.1 50.0±9.7 53.3±11.0
Median (IQR) 56 47-65 48 42.5-55.7 52 44-60
BMI, kg/m2 n=99 n=33 n=95
Interval 17.4 to 33.8 17.3 to 26.9 18.3 to 31.0
<0.001 <0.001
Mean±SD 24.8±3.2 21.4±2.3 23.3±2.9
Prostatic volume (DR) (g) n=99 n=32 n=93








Prostatic volume (DR) (g) n=99 n=32 n=93
≤20 52 (52.5) 27 (84.4) 57 (61.3) 0.0058
>20 47 (47.5) 5 (15.6) 36 (38.7)
Total Testosterone (ng/dL) n=34 n=8 n=23
Interval 99-826 66-550 14-889
0.207 0.390
Mean±DP 502.2±177.7 414.4±155.6 512.2±185.0
PSA (ng/mL) n=54 n=11 n=38
Interval 0.1-13.9 0.03 and 6.2 0.02-5.1


































n=number of individuals with available data; DR=digital rectal exam; IQR=interval interquartis; PSA=prostatic specific antigen; SD=standard deviation
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Table 4 - Frequency of variants TP53 and GSTP1 in non-Indians and Indias.
Characteristic Non-Indians Indians P*
TP53
Arg/Arg (GG) 37 (42.5%) 152 (74.5%)
Arg/Pro (GC) 39 (44.8%) 42 (20.6%) <0.0001
Pro/Pro (CC) 11 (12.6%) 10 (4.9%)
GSTP1
Ile/Ile (A/A) 53 (60.9%) 73 (35.3%)
Ile/Val (A/G) 25 (28.7%) 95 (45.9%) 0.0003
Val/Val (G/G) 9 (10.3%) 39 (18.8%)
A=Adenin; Arg=Arginin; C=Citosine; G=Guanine; Ile=Isoleucin; Pro=Proline; Val=Valin.
*Chi-square








Ethnical group n=151 n=42 n=10
Macuxi 70 (46.4) 13 (30.9) 2 (20)
Yanomami 21 (13.9) 7 (16.7) 0 0.0637*
Other ethnical groups 60 (39.7) 22 (52.4) 8 (80)
Smoking n=152 n=42 n=10
No 55 (38.7) 15 (35.7) 4 (40.0) 0.9674*
Yes 97 (63.8) 27 (64.3) 6 (60.0)
Alcohol abuse n=152 n=42 n=10
No 65 (42.8) 16 (38.1) 7 (70) 0.1840*
Yes 87 (57.2) 26 (61.9) 3 (30)
Age, years n=152 n=42 n=10
Interval 40.0 a 91.0 40.0 a 81.0 40.0 a 78.0
Median (IIQ) 52.0 (44.0-63.0) 54.5 (45.0-61.0) 56.0 (47.0-68.0) 0.7303**
IIQ=interval interquartil; Arg=Arginin; Pro=Prolin.
*Chi-square; **Kruskal-Wallis.
Mexico and non-hispanic whites, with the lower 
incidence among Indians (1).
Although different incidences of PCa 
among ethnic groups exist due to different scre-
ening methods and access to health care (13), se-
veral exogenous risk factors may contribute to the 
disparity of risks, including dietary habits, lifesty-
le and genetic predisposition (16).
The association of prostate cancer, inges-
tion of saturated fat, BMI and physical activity 
was observed in many ethnic groups (14), along 
with the association of the size of body, in particu-
lar waist-hip, with PCa in Chinese men (17).
Several studies suggest that PCa incidence 
is related to the visited country. Changes in lifes-
tyle and dietary habits have great impact, increa-
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Ethnical group n=73 n=94 n=39
Macuxi 29 (39.7) 42 (44.7) 16 (41.0) 0.6513*
Yanomami 12 (16.4) 14 (14.9) 3 (7.7)
Other ethnical groups 32 (43.8) 38 (40.4) 20 (51.3)
Smoking n=73 n=95 n=39
No 27 (37.0) 33 (34.7) 14 (35.9) 0.9553*
Yes 46 (63.0) 62 (65.3) 25 (64.1)
Alcohol abuse n=73 n=95 n=39
No 37 (50.7) 38 (40.0) 15 (38.5) 0.2997*
Yes 36 (49.3) 57 (60.0) 24 (61.5)
Age, years 
Interval 40.0 a 88.0 40.0 a 91.0 40.0-84.0 0.3975**
Median (IIQ) 50.0 (44.0-63.0) 53.0 (45.0-62.0) 55.0 (45.2-64.7)
IIQ=interval interquartil; Ile=Isoleucin; Val=Valin.
*Chi-square: **Kruskal-Wallis
sing three to seven times the incidence of PCa in 
first generation of American Japanese and Chine-
se, whose fathers migrated to USA (18, 19). Ho-
wever, the impact of diet is still controversial and 
data related to Indian nutritional status are rare.
 In men, testosterone is the main circu-
lating androgen, with major role in male phy-
siology, in particular prostate. We observed that 
Yanomamis present lower levels of testosterone 
(414 ng/dL) in relation to other ethnic groups 
(502/512 ng/dL), but still within normal limits 
(350-1000 ng/dL).
We have also observed a particular diffe-
rence of size and consistency of prostate during 
DR in Indians in relation to non-indigenous pa-
tients. It was observed a “minimum” gland with a 
more fibroelastic consistency, sometimes not de-
tectable during digital rectal exam in the Indian 
population. We think that, more than isolated hor-
monal factors, the ingestion of several plants and 
the genetic background are the principal causes 
of this characteristic of physical exam of Indians.
The analysis of serum PSA using diffe-
rent thresholds revealed that 5.8% of participants 
had total PSA≥4.0 ng/mL and 8.7% >2.5 ng/mL. 
In accordance to other studies (20-23), we have 
observed a rise of PSA levels with age in our po-
pulation, indicating that the rise of PSA with age 
of Brazilian Indians is in accordance to general 
population.
In our casuistic abdominal circumference 
(90 cm is the threshold value) did not correlated to 
lower urinary tract symptoms (obstructive and/or 
irritative), as well as to prostatic cancer, in accor-
dance do European results (24, 25).
Genetically, our data show that none pa-
tients of Yanomami group presented the genotype 
Pro/Pro of p53, compared to 2.02% of Macuxi, 
8.3% in other ethnic groups and 12.6% in the con-
trol group, highlighting the miscegenation of the 
genotype Pro/Pro of p53.
Wu et al. demonstrated that genotypes 
Arg/Pro and Pro/Pro related to the susceptibili-
ty to Pca in Chinese men (26), in accordance to 
Quiñones et al. in Chilean patients (27). Howe-
ver, Henner et al. reported that the genotype Pro/
Pro could be related to protection against PCa in 
Caucasian men (28).
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Genotypic divergence of Yanomami po-
pulation may be explained by intercrossing of 
consanguineous marriages, and the genes being 
transmitted from only one ancestral. Another 
aspect is the subdivision of population in iso-
lated groups, separated by geographic, political, 
socioeconomic, religious and cultural barriers, 
preventing the exchange of genes by interethnic 
marriages (29).
When we evaluated the genotypic profile 
results of GSTP1, again we observed difference 
between Indians and non-Indians. The frequency 
of variant genotypes Ile/Val and Val/Val is lower 
among Indians, raising again the hypothesis of 
the above factors for p53 being related to such 
genotypic profile. Among the Yanomami studied, 
the homozygous genotype Val/Val was observed 
in only three cases (7.7%).
A meta-analysis study of genotypes 
GSTM1, GSTT and GSTP1 including 11 studies 
(2.528 patients and 3.076 controls) concluded that 
these three polymorphisms are not important fac-
tors for the susceptibility to PCa (30) but Indian 
populations were not represented.
In our sample, the number of participants 
per ethnic group is relatively small and the es-
timates of race, ethnic group and comparison 
among groups were restricted to Macuxis, Yano-
mamis and “other ethnic groups” as a third group.
On the other hand, this study so far is one 
with the biggest casuistic of Amazon Indians eva-
luated urologically, anthropometrically and gene-
tically (P53 codon 72 and GSTP1). Although with 
a restrict number of controls (n=87), the results 
suggest differences of the genetic profile of In-
dians, maybe related to risk-protection patterns 
that explain the low prostate volume and the rela-
tively low incidence of prostatic diseases in these 
populations.
Limits of the study: although we had not 
compared dietary details with the ingestion of sa-
tured fat or industrial products among ethnical 
groups, it is evident that hunt meat is the basis 
of Indian diet; although the detailed comparison 
between ethnical groups more or less culturalized 
was obtained, the comparison with the control 
group of non-indigenous individuals was limited 
to genetic, age and tobacco use.
New Indian population studies are necessa-
ry to measure and follow the epidemiological mo-
difications due to contact among Indians and non-
-Indians, in order to stablish health care guidelines, 
in particular preventive ones, directed to the new 
reality of the studied population. These new studies 
may reveal the impact of inheritance of detoxifica-
tion genes as polymorphisms of GSTP1 and TP53, 
along with the recognition and elimination of toxic 
dietary products related to prostatic diseases.
CONCLUSIONS
Indians, in particular Yanomamis, present 
low prostatic volume, lower BMI and different geno-
typic profile of GSTP1 and TP53 codon 72, althou-
gh with similar PSA and testosterone levels to other 
ethnic groups. These aspects may be related to good 
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